Carmine N. Stengone

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

CTNM

Current role

Board Member, CEO

1 call Latest call 2025-10-30

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Contineum Therapeutics, Inc. (CTNM)	President and Chief Executive Officer	$655,620	—	—	$2,291,640	$450,739	$11,449	$3,409,448
2024	Contineum Therapeutics, Inc. (CTNM)	President and Chief Executive Officer	$608,120	$55,000	—	$3,806,147	$418,146	$12,627	$4,900,039
2023	Contineum Therapeutics, Inc. (CTNM)	President and Chief Executive Officer	$515,595	$55,000	—	$1,525,000	$207,527	$12,177	$2,315,299

Earnings-call appearances and filed executive appointments or departures, newest first.